Daly Richard J — SEC Form 4 filings

SEC reporting owner CIK 1635393. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.

Transaction summary — filings shown

Covers all 12 filings on record, filed 2024-02-16 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CATALYST PHARMACEUTICALS, INC. (CPRX)President and CEO, Director123 legs · 110,293 sh · $2,490,57640

Form 4 filings — Daly Richard J

FiledFormIssuerReported transactionsSource
2026-07-174CATALYST PHARMACEUTICALS, INC. (CPRX)Disposition to issuer (D): 271,266 @ $31.50 · Disposition to issuer (D): 33,500 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 15,000 (derivative) @ $0 · Disposition to issuer (D): 1,365,319 (derivative) @ $0 · +5 moreEDGAR
2026-01-064CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 42,105 · Tax withholding (F): 10,577 · Option exercise (M): 42,105 (derivative) @ $0EDGAR
2025-12-304CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 1,334 · Tax withholding (F): 524 · Option exercise (M): 1,334 (derivative) @ $0EDGAR
2025-11-244CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 20,006 · Tax withholding (F): 7,872 · Grant/award (A): 381,948 (derivative) @ $0 · Grant/award (A): 115,283 (derivative) @ $0 · Option exercise (M): 20,006 (derivative) @ $0EDGAR
2025-08-284CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 50,000 @ $2.24 · Sale (S): 22,970 @ $20.62 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2025-06-034CATALYST PHARMACEUTICALS, INC. (CPRX)Sale (S): 70,000 @ $24.86EDGAR
2025-02-194CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 4,000 · Tax withholding (F): 1,574 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2025-01-034CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 42,105 · Tax withholding (F): 10,600 · Option exercise (M): 42,105 (derivative) @ $0EDGAR
2024-12-314CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 1,333 · Tax withholding (F): 324 · Option exercise (M): 1,333 (derivative) @ $0EDGAR
2024-11-254CATALYST PHARMACEUTICALS, INC. (CPRX)Grant/award (A): 491,160 (derivative) @ $0 · Grant/award (A): 60,019 (derivative) @ $0EDGAR
2024-06-054CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 40,000 @ $4.01 · Sale (S): 17,323 @ $15.97 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2024-02-164CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 4,000 · Tax withholding (F): 1,186 · Grant/award (A): 4,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1635393 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →